Lutetium-177 rhPSMA-10.1
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lutetium-177 rhPSMA-10.1, covering 2025-09-25 to 2025-09-25. Get the full timeline:
Most recent: Clinical Trial Update: A Dosimetry Study of Lutetium (177Lu) rhPSMA-10.1 and Lutetium (177Lu) Vipivotide Tetraxetan (Pluvicto®) in Patients With Non-curative Metastatic Prostate Cancer [EARLY_Phase 1]